Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
This Week In Space podcast: Episode 192 — Space, 2026! - 2Top 10 Arising Advances That Will Shape What's in store
- 3Figure out How to Really focus on Your Dental Inserts for Durable Outcomes
- 4Overseeing Individual budgets Successfully
- 5Bolsonaro says hallucinatory effects of meds made him tamper with ankle tag
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- Figure out How to Use Your Nursing Abilities for Better Compensation
- FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- Inside Kathy Hilton’s Christmas pajama party: caviar bumps, champagne vending machines and a mansion full of Housewives
- Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- How to watch 'Tell Me Lies' Season 3: Episode release times, streaming info and more
- Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- 2023's Best 10 Cell phone Advancements You Can't Miss
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
